Clinical Trials Browser

Phase EARLY_PHASE1 × darolutamide × Clear all

NCT05683964 2026-02-13

Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression

Phase EARLY_PHASE1 Active not recruiting

Prostatic Neoplasms

NCT03004534 2020-04-03

A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide

Phase EARLY_PHASE1 Completed

36 enrolled 10 charts

Breast Neoplasms